A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2002
12/04/2002	EP0814837B1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis
12/04/2002	EP0752863B1 Use of biopolymers for digestive tract injuries treatment
12/04/2002	EP0719285B1 Il8 inhibitors
12/04/2002	CN1383452A Compsns. and methods for treating cells having double minute DNA
12/04/2002	CN1383428A Medicinal compsns. having antiplasmid effect and its prepn. method
12/04/2002	CN1383380A 干细胞增强材料 Stem Cell Reinforcements
12/04/2002	CN1382682A 2-(alpha-hydroxypentyl) benzoate and its preparing process and usage
12/04/2002	CN1382490A Treatment application of selectivity PDE10 suppressant
12/04/2002	CN1382481A Compound buccal lozenge as Chinese medicine for protecting eyes and refreshing brain
12/04/2002	CN1382476A Application of yellowstem milkwort in preparing medicines
12/04/2002	CN1382457A Powdered medicine for preventing and treating epimedic diseases of livestocks and fowls
12/04/2002	CN1382450A Stem cell medicine for repairing damage of central nerve and its preparing process
12/04/2002	CN1382442A Method for preventing dyskinesia
12/04/2002	CN1382440A Method and medicine case for treating depression or preventing degeneration of cognitive function
12/04/2002	CN1382377A Operation for onzyme activity of protoporphyrin prooxidase in eukaryotic organism
12/04/2002	CA2384907A1 Methods and compositions relating to mek5 and cardiac hypertrophy and dilated cardiomyopathy
12/03/2002	US6489476 Fructose-1,6-bisphosphatase enzyme inhibitors are useful in the treatment of diabetes and other conditions associated with elevated blood glucose or excess glycogen storage.
12/03/2002	US6489475 Method of producing heterocyclic derivatives
12/03/2002	US6489353 Antiinflammatory agents; autoimmune diseases; central nervous system disorders
12/03/2002	US6489352 Antiepileptic agents; nervous system disorders
12/03/2002	US6489349 Treating an autoimmune disorder with an alkylamine substituted pyridine
12/03/2002	US6489347 Process
12/03/2002	US6489344 For treatment diabetes in a human or animal subject
12/03/2002	US6489333 Heterocyclic compounds containing a guanidine mimic, for inhibition of cell adhesion, treatment of angiogenesis disorders, inflammation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration
12/03/2002	US6489328 Heterocyclic compounds useful as inhibitors of tyrosine kinases
12/03/2002	US6489327 Tryptase inhibitors
12/03/2002	US6489324 Piperazine compounds as inhibitors of MMP or TNF
12/03/2002	US6489323 Inhibiting no production from l-arginine, as seen in disease states such as arthritis and systemic hypotension associated with septic and/or toxic shock
12/03/2002	US6489322 Benzoxazepines as selective inhibitors of the neuronal isoform of nitric oxide synthase for treatment of neurodegenerative disease
12/03/2002	US6489311 Using heparin or noncoagulant heparin in the prevention of apoptosis in ischemic-reperfused myocardium and/or brain
12/03/2002	US6489307 Reducing the level of transcription of beta 1-adrenoceptor polypeptide-specific mrna in a mammalian host cell, by administering oligonucleotide; reduces receptor expression; hypotensive effect
12/03/2002	US6489298 Contulakin-G, analogs thereof and uses thereof
12/03/2002	US6489296 Treatment of hypercoagulable states or acquired protein c deficiency with activated protein c, a highly selective therapeutic agent with a low potential for causing bleeding complications
12/03/2002	US6489295 Antagonists of intestinotrophic GLP-2 peptides
12/03/2002	US6489294 Truncated insulin-like growth factor binding protein-5 having mitogenic activity
12/03/2002	US6489137 For use in cancer diagnostics; detection of the loss and or alteration of wild-type hubub1 genes in tumor tissues
12/03/2002	US6489134 Kinesin motor modulators derived from the marine sponge Adocia
12/03/2002	US6489130 Death associated kinase containing ankyrin repeats (DAKAR)
12/03/2002	US6488951 Stable NO-delivering compounds
12/03/2002	US6488930 Antibody or functional fragment thereof which binds to a mammalian (e.g., human) cc-chemokine receptor 4 (ccr4)
12/03/2002	US6488923 Inhibits elastase; inhibits inflammations; used for the preparation of a vasoregulatory and or collagen activating medicament and to treat gingivitis.
12/03/2002	US6488032 Method of providing cosmetic/medical therapy
12/03/2002	CA2283915C The use of alkyl hydrogen fumarates for treating psoriasis, psoriatic arthritis, neurodermatitis and enteritis regionalis crohn
12/03/2002	CA2266107C Aralkyl and aralkylidene heterocyclic lactams and imides
12/03/2002	CA2216617C New flavone derivatives, their preparation procedures and the pharmaceutical compositions containing them
12/03/2002	CA2213198C Gene therapy by anti-tgf-b agents
12/03/2002	CA2206837C Use of strontium salts to obtain pharmaceutical compositions intented for the treatment of arthrosis
12/03/2002	CA2107481C Osteoinductive protein mixtures and purification processes
12/03/2002	CA2074933C Thiazole derivatives as active superoxide radical inhibitors
12/03/2002	CA2073856C Glp-1 analogs useful for diabetes treatment
12/03/2002	CA2042668C Treatment of amyloidosis associated with alzheimer's disease
11/2002
11/30/2002	CA2389560A1 Cosmetic and/or dermatological and/or pharmaceutical compound for topical application, containing at least one 3 beta-hydroxysteroid dehydrogenase enzyme inhibitor
11/30/2002	CA2387699A1 Combination treatment for sleep disorders including sleep apnea
11/29/2002	WO2001093899A1 PANCREATIC LANGERHANS β CELL PROLIFERATION PROMOTER AND APOPTOSIS INHIBITOR, AND SCREENING OF CANDIDATE COMPOUNDS FOR THE E DRUGS
11/29/2002	CA2410918A1 Agents for proliferating pancreatic beta-cells of the islets of langerhans, agents for suppressing apoptosis of said cells, and screening of candidate compounds for these agents
11/28/2002	WO2002095704A1 Use of nf-kappa-b inhibitors to treat dry eye disorders
11/28/2002	WO2002095391A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002095043A1 Cellular signal-responsive gene transcriptional regulation system
11/28/2002	WO2002095026A1 Method of proliferating terminal differentiated cells and recombinant vector therefor
11/28/2002	WO2002095025A1 Novel smg-1
11/28/2002	WO2002095017A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002	WO2002095015A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody
11/28/2002	WO2002095007A2 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002	WO2002094876A2 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002	WO2002094873A2 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use
11/28/2002	WO2002094864A2 Human cdnas and proteins and uses thereof
11/28/2002	WO2002094836A2 Methods for preparation and use of psorospermin analogs
11/28/2002	WO2002094834A1 Imidazo [1,5-a] pyrimido [5,4-d] benzazepine derivatives as gaba a receptor modulators
11/28/2002	WO2002094833A1 Novel pyrrole derivatives as pharmaceutical agents
11/28/2002	WO2002094830A2 DIHYDROPYRROLO[1,2-A]INDOLE AND TETRAHYDROPYRIDO[1,2-a]-INDOLE DERIVATIVES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
11/28/2002	WO2002094826A1 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists
11/28/2002	WO2002094825A1 Novel spiropiperidine derivative
11/28/2002	WO2002094824A1 Pyridopyrimidine compounds and their uses
11/28/2002	WO2002094823A1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
11/28/2002	WO2002094821A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	WO2002094814A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors
11/28/2002	WO2002094812A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	WO2002094811A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	WO2002094810A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	WO2002094809A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002	WO2002094808A1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors
11/28/2002	WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	WO2002094795A1 4-aminopyrimidine derivatives
11/28/2002	WO2002094790A1 Fused heterocyclic compound and medicinal use thereof
11/28/2002	WO2002094788A1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
11/28/2002	WO2002094786A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002	WO2002094785A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	WO2002094768A2 Aza hydroxylated ethyl amine compounds
11/28/2002	WO2002094767A2 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
11/28/2002	WO2002094342A2 Compositions for protein delivery via the pulmonary route
11/28/2002	WO2002094322A2 Combination medicament for treatment of neoplastic diseases containing cyanoguanidine ikk inhibitors and a second anti-neoplastic drug
11/28/2002	WO2002094311A1 Use of proteasome inhibitors to treat dry eye disorders
11/28/2002	WO2002094306A1 Remedies for nervous tumor
11/28/2002	WO2002094304A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
11/28/2002	WO2002094300A1 Herbal compositions for the treatment of mucosal lesions
11/28/2002	WO2002094297A1 Herbal composition for the treatment of drug addiction and insomnia
11/28/2002	WO2002094294A1 A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation
11/28/2002	WO2002094288A1 Veterinary compositions comprising avermectin-oxime derivatives and praziquantel
11/28/2002	WO2002094285A1 Single-daily-dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle

1 ... 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 ... 1564